Zhiyong Peng, MD, PhD

Zhiyong Peng, MD, PhDZhiyong Peng, MD, PhD

Director of World’s First Randomized IV Vitamin C Clinical Trial
Vice - Director, Center for Clinical Trials, Wuhan University
Chairman, Critical Care Medicine, Zhongnan Hospital

ITM BIO:
Dr. Zhiyong Peng

         Press Release: Orthomolecular Medicine News Service,

       Feb 13, 2020

“Coronavirus Patients in China to be Treated with High-Dose Vitamin C”


ITM NEWS Update
:  Published on July 8, 2020,  Dr. Zhiyong Peng initiates the first China based multi-center High-dose IV Vitamin C. clinical trial:  BMJ Open: ICU Protocol: Intravenous high-dose vitamin C for the treatment of severe COVID-19:     https://bmjopen.bmj.com/content/bmjopen/10/7/e039519.full.pdf

Zhiyong Peng, MD, PhDDr. Peng finds himself in high demand as a COVID-19 consultant to his global peers
as Director of the world’s first randomized high-dose IV vitamin C clinical trial.

Dr. Zhiyong Peng is interviewed by Richard Cheng, MD, PhD, Director of the Medical & Scientific Advisory Board to the International Intravenous Vitamin C China Epidemic Medical Support Team, in an international video conference.  
 
London-based Patrick Holford, one of the world’s leading authorities on health & nutrition, interviews Dr. Zhiyong Peng on the success of IV Vitamin C for treating patients infected by the coronavirus.

Zhiyong Peng, MD, PhD

ITM Global Release in two languages:
April 14, 2020 


ITM: China Leads the Way to Saving Lives and it is Good News for NYC -- Critically Ill COVID-19 Patients  are being Successfully Treated

ITM: 击败冠状病毒性肺炎治疗早期发作和危重住院患者的方法到来了
 
Professional Memberships and Associations  
Research Publications 

WE APPRECIATE YOUR INTEREST TO LEARN MORE!

Ask about our Life Saving Ambassador Programs for your city, state, or country.

LOCATION

Find us on the map

Office Hours

Primary

Monday:

9:00 am-5:00 pm

Tuesday:

9:00 am-5:00 pm

Wednesday:

9:00 am-5:00 pm

Thursday:

9:00 am-5:00 pm

Friday:

9:00 am-5:00 pm

Saturday:

Closed

Sunday:

Closed